SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-22-000156
Filing Date
2022-03-04
Accepted
2022-03-04 16:11:01
Documents
75
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K body10-k.htm   iXBRL 10-K 1409842
2 DESCRIPTION OF SECURITIES OF SEELOS THERAPEUTICS, INC. exh4-21.htm EX-4.21 43936
3 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE exh4-22.htm EX-4.22 13665
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exh23-1.htm EX-23.1 2317
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exh31-1.htm EX-31.1 10360
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 10354
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS exh32-1.htm EX-32.1 3267
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS exh32-2.htm EX-32.2 3279
9 GRAPHIC image_001.gif GRAPHIC 2393
  Complete submission text file 0001136261-22-000156.txt   6541690

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE seel-20211231.xsd EX-101.SCH 61207
11 XBRL CALCULATION FILE seel-20211231_cal.xml EX-101.CAL 49102
12 XBRL DEFINITION FILE seel-20211231_def.xml EX-101.DEF 240465
13 XBRL LABEL FILE seel-20211231_lab.xml EX-101.LAB 398671
14 XBRL PRESENTATION FILE seel-20211231_pre.xml EX-101.PRE 351145
69 EXTRACTED XBRL INSTANCE DOCUMENT body10-k_htm.xml XML 860068
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22245 | Film No.: 22714169
SIC: 2834 Pharmaceutical Preparations